Fusobacterium

A Gram-negative, obligate anaerobic bacterium that has emerged as the most consistently CRC-associated microorganism in human gut microbiome studies. F. nucleatum is the primary species of concern, originally a commensal of the oral cavity that translocates to colorectal tumors where it promotes tumorigenesis through multiple virulence mechanisms. It was the most frequently cancer-enriched genus across 45 cancer studies in a major meta-analysis [1].

Mechanisms of Colorectal Carcinogenesis

F. nucleatum drives CRC through a convergence of adhesion, immune evasion, and pro-tumorigenic signaling:

Adhesion and Invasion

  • FadA adhesin binds host E-cadherin on colonocytes, disrupting cell-cell junctions and activating the Wnt/beta-catenin signaling pathway. This promotes uncontrolled epithelial proliferation and is the primary oncogenic mechanism [2].
  • Fap2 lectin binds the Gal-GalNAc sugar moiety overexpressed on CRC tumor cells, enabling selective homing to tumor tissue rather than normal mucosa.

Immune Evasion

  • Fap2 also binds the TIGIT inhibitory receptor on NK cells and T cells, directly suppressing anti-tumor immune surveillance. This represents a microbial immune checkpoint exploitation [2].
  • LPS-TLR4 interaction activates NF-kB signaling, promoting chronic inflammation in the tumor microenvironment.
  • Induces autophagy pathways (ULK1/ATG7) in CRC cells, contributing to chemotherapy resistance (5-FU, oxaliplatin).

Pro-inflammatory Signaling

  • Activates NF-kB and STAT3 pathways, creating a self-reinforcing inflammatory tumor niche.
  • Recruits myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs) to the tumor microenvironment.

Iron Dependency

  • F. nucleatum has an obligate iron requirement for growth, relying on FeoB and other iron acquisition systems.
  • Thrives in the iron-rich tumor microenvironment created by hemorrhagic necrosis in advanced CRC.
  • Iron supplementation in the gut may inadvertently promote Fusobacterium expansion, linking iron overload to CRC risk.
  • Forms iron-dependent biofilm communities in colorectal tumors, creating a protected niche resistant to host immunity and antibiotics.

Oral-Gut Translocation

  • The oral cavity is the primary reservoir; F. nucleatum reaches the colon via hematogenous spread or direct swallowing.
  • Oral health (periodontitis, gingivitis) is a risk factor for CRC, mediated partly through Fusobacterium translocation.
  • Strain-specific analysis confirms identical clones in matched oral and tumor samples, establishing the oral-gut-tumor migration pathway.

Disease Associations Beyond CRC

  • IBD: enriched in Crohn's disease and ulcerative colitis tissue, particularly in inflamed segments.
  • Pancreatic cancer: detected in pancreatic tumor tissue; associated with poor prognosis.
  • Esophageal and gastric cancers: enriched in upper GI malignancies.
  • Adverse pregnancy outcomes: F. nucleatum hematogenous spread linked to preterm birth and chorioamnionitis.

Key Metabolites

  • Hydrogen sulfide (H2S) — produces H2S via cysteine desulfhydrase, contributing to DNA damage and oxidative stress in colonocytes.
  • Formate and butyrate — mixed acid fermentation products; butyrate paradoxically fuels CRC cells exhibiting the Warburg effect.
  • Short-chain fatty acids — metabolic cross-feeding with other tumor-associated bacteria sustains the CRC microenvironment.

Key Sources

Connections

  • colorectal cancer — THE defining CRC-associated bacterium; FadA/Fap2 virulence mechanisms
  • iron — obligate iron requirement; thrives in iron-rich tumor environments
  • inflammation — activates NF-kB/STAT3; chronic inflammatory signaling in tumors
  • biofilm — forms iron-dependent biofilms in colorectal tumors
  • dysbiosis — its enrichment is a hallmark of cancer-associated dysbiosis
  • oxidative stress — H2S production drives DNA damage in colonocytes
  • cardiovascular disease — oral Fusobacterium contributes to systemic inflammation
  • enterobacteriaceae — co-enriched in cancer and inflammatory disease states
  • faecalibacterium prausnitzii — inversely correlated; F. prausnitzii depletion accompanies Fusobacterium expansion
  • gut metal microbiome — iron availability in the gut modulates Fusobacterium competitive advantage
  • gastric cancer — enriched in gastric tumor tissue alongside H. pylori
  • ovarian cancer — enriched in ovarian tumor tissue; FadA-mediated E-cadherin/beta-catenin activation

References (5)

  1. Md Zohorul Islam, Melissa Tran, Tao Xu et al. (2022). Reproducible and opposing gut microbiome signatures distinguish autoimmune diseases and cancers: a systematic review and meta-analysis. Microbiome. doi:10.1186/s40168-022-01373-1
  2. Hanus M, Parada-Venegas D, Landskron G et al. (2021). Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment. Frontiers in Immunology. doi:10.3389/fimmu.2021.612826
  3. Appunni S, Rubens M, Ramamoorthy V et al. (2021). Emerging Evidence on the Effects of Dietary Factors on the Gut Microbiome in Colorectal Cancer. Frontiers in Nutrition. doi:10.3389/fnut.2021.718389
  4. Shaomin Zou, Chao Yang, Jieping Zhang et al. (2024). Multi-omic profiling reveals associations between the gut microbiome, host genome and transcriptome in patients with colorectal cancer. Journal of Translational Medicine. doi:10.1186/s12967-024-04984-4
  5. Wantong Song, Leaf Huang (2025). Targeting tumor-associated microbiome: A new aspect of modulating tumor microenvironment for cancer therapy. Advanced Drug Delivery Reviews. doi:10.1016/j.addr.2025.115554

Related Articles